Homburger has advised the shareholders of Evax AG. Schellenberg Wittmer has advised Boehringer Ingelheim. Boehringer Ingelheim has completed the acquisition of Evax AG, a Swiss biotechnology...
Boehringer Ingelheim Acquires Swiss Biotech Firm Evax AG
Starmind Acquired by US-Based AI Platform Capacity
Wenger Vieli has advised the shareholders of Starmind. Schellenberg Wittmer has advised Capacity. Starmind, a Swiss provider of AI-based knowledge solutions, has been acquired by Capacity,...
ams OSRAM Sells Sensor Business Unit to Infineon Technologies for €570 Million
Linklaters and Schellenberg Wittmer have advised ams OSRAM on the sale of part of its sensor business to Infineon Technologies. ams OSRAM has entered into an...
ams-OSRAM AG Announces Partial Repurchase of Convertible Bond via Dutch Auction
Schellenberg Wittmer has advised ams-OSRAM AG. ams-OSRAM AG, a global leader in innovative light and sensor solutions and listed on the SIX Swiss Exchange, has announced...
Coca-Cola Beverages Africa Majority Stake Sold to Coca-Cola HBC AG
Schellenberg Wittmer and Mc Dermott Will & Schulte have advised The Coca-Cola Company and Gutsche Family Investments. Pestalozzi advises Coca-Cola HBC AG. The Coca-Cola Company and...
Morimatsu Group Acquires Bioengineering AG to Expand Life Sciences Portfolio
Niederer Kraft Frey has advised the former owners of Bioengineering AG. Schellenberg Wittmer advised Morimatsu Group. Morimatsu Group has completed the acquisition of Bioengineering AG, a...
Focuslight Technologies Inc.’s Acquisition Of Passive Optical Components Assets From ams-OSRAM AG
Schellenberg Wittmer advised SIX Swiss Exchange-listed ams-OSRAM AG on the sale of its Passive Optical Components Assets. Focuslight Technologies Inc., a global provider of high-power diode...
Boehringer Ingelheim’s Acquisition Of Saiba Animal Health AG
Schellenberg Wittmer advised Boerhringer Ingelheim on the deal. Boehringer Ingelheim has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines...
Chiesi Farmaceutici S.p.A.’s Acquisition of Raxone/idebenone From Santhera Pharmaceuticals AG
Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the operation. Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the sale of its Raxone®/idebenone business for all...
ÖBB’s Acquisition of 33.4% of Shares in Railtour Suisse SA
Schellenberg Wittmer advised Österreichische Bundesbahnen (ÖBB) on the deal. The ÖBB tour operator Rail Tours (Australian Railways) has joined the DER subsidiary Railtour Suisse in Switzerland...
Asker Healthcare Group’s Acquisition of Aichele Medico
Schellenberg Wittmer advised Asker Healthcare Group on the deal. Asker Healthcare Group announced its acquisition of all shares in the Swiss medical supplies distributor Aichele Medico AG...
Swiss Post Solutions AG’s Acquisition of Avaloq Outline AG
Schellenberg Wittmer advised Avaloq Group on the deal. Avaloq Group announced its sale of Avaloq Outline AG, a global outsourcing provider for business process solutions and...